Comparative analysis of gO isoforms reveals that strains of human cytomegalovirus differ in the ratio of gH/gL/gO and gH/gL/UL128-131 in the virion envelope

Journal of Virology

Volumn 87, Issue 17, 2013, Pages 9680-9690

  Zhou, Momei ^a   Yu, Qin ^a   Wechsler, Anya ^a   Ryckman, Brent J ^a  

^a UNIVERSITY OF MONTANA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CHAPERONE; HYBRID PROTEIN; ISOPROTEIN; MERLIN; PROTEIN AD169; PROTEIN GH GI; PROTEIN GH GL; PROTEIN GH GL GO; PROTEIN GH GL UL128 131; PROTEIN GO; PROTEIN PH; PROTEIN TB40 E; PROTEIN TR; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; VIRUS PROTEIN;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; VIRION; VIRUS CELL INTERACTION; VIRUS ENVELOPE; VIRUS STRAIN;

ADENOVIRUSES, HUMAN; AMINO ACID SEQUENCE; CELL LINE; CROSS REACTIONS; CYTOMEGALOVIRUS; GENETIC VECTORS; HUMANS; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; MULTIPROTEIN COMPLEXES; MUTATION; PHYLOGENY; PROTEIN ISOFORMS; SEQUENCE HOMOLOGY, AMINO ACID; VIRAL ENVELOPE PROTEINS; VIRAL PROTEINS; VIRION; VIRULENCE; VIRUS ASSEMBLY;

EID: 84883294676     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01167-13     Document Type: Article

References (66)

1. Britt WJ. 2008. Manifestations of human cytomegalovirus infection: proposed mechanisms of acute and chronic disease. Curr. Top. Microbiol. Immunol. 325:417-470.
2. Landolfo S, Gariglio M, Gribaudo G, Lembo D. 2003. The human cytomegalovirus. Pharmacol. Ther. 98:269-297.
3. Pass R, Fowler K, Boppana S, Britt W, Stagno S. 2006. Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome. J. Clin. Virol. 35:216-220.
4. Streblow D, Orloff S, Nelson J. 2007. Acceleration of allograft failure by cytomegalovirus. Curr. Opin. Immunol. 19:577-582.
5. Plachter B, Sinzger C, Jahn G. 1996. Cell types involved in replication and distribution of human cytomegalovirus. Adv. Virus Res. 46:195-261.
6. Sinzger C, Grefte A, Plachter B, Gouw A, The T, Jahn G. 1995. Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues. J. Gen. Virol. 76:741-750.
7. Murphy E, Rigoutsos I, Shibuya T, Shenk T. 2003. Reevaluation of human cytomegalovirus coding potential. Proc. Natl. Acad. Sci. U. S. A. 100:13585-13590.
8. Rigoutsos I, Novotny J, Huynh T, Chin-Bow ST, Parida L, Platt D, Coleman D, Shenk T. 2003. In silico pattern-based analysis of the human cytomegalovirus genome. J. Virol. 77:4326-4344.
9. Varnum S, Streblow D, Monroe M, Smith P, Auberry K, Pasa-Tolic L, Wang D, Camp DN, Rodland K, Wiley S, Britt W, Shenk T, Smith R, Nelson J. 2004. Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome. J. Virol. 78:10960-10966.
10. Atanasiu D, Saw W, Cohen G, Eisenberg R. 2010. Cascade of events governing cell-cell fusion induced by herpes simplex virus glycoproteins gD, gH/gL, and gB. J. Virol. 84:12292-12299.
11. Backovic M, Longnecker R, Jardetzky T. 2009. Structure of a trimeric variant of the Epstein-Barr virus glycoprotein B. Proc. Natl. Acad. Sci. U. S. A. 106:2880-2885.
12. Chowdary T, Cairns T, Atanasiu D, Cohen G, Eisenberg R, Heldwein E. 2010. Crystal structure of the conserved herpesvirus fusion regulator complex gH-gL. Nat. Struct. Mol. Biol. 17:882-888.
13. Connolly SA, Jackson JO, Jardetzky TS, Longnecker R. 2011. Fusing structure and function: a structural view of the herpesvirus entry machinery. Nat. Rev. Microbiol. 9:369-381.
14. Heldwein E, Lou H, Bender F, Cohen G, Eisenberg R, Harrison S. 2006. Crystal structure of glycoprotein B from herpes simplex virus 1. Science 313:217-220.
15. Matsuura H, Kirschner A, Longnecker R, Jardetzky T. 2010. Crystal structure of the Epstein-Barr virus (EBV) glycoprotein H/glycoprotein L (gH/gL) complex. Proc. Natl. Acad. Sci. U. S. A. 107:22641-22646.
16. Hutt-Fletcher LM. 2007. Epstein-Barr virus entry. J. Virol. 81:7825-7832.
17. Mori Y, Akkapaiboon P, Yonemoto S, Koike M, Takemoto M, Sadaoka T, Sasamoto Y, Konishi S, Uchiyama Y, Yamanishi K. 2004. Discovery of a second form of tripartite complex containing gH-gL of human herpesvirus 6 and observations on CD46. J. Virol. 78:4609-4616.
18. Chesnokova L, Hutt-Fletcher LM. 2011. Fusion of Epstein-Barr virus with epithelial cells can be triggered by αvβ5 in addition to αvβ6 and αvβ8, and integrin binding triggers a conformational change in glycoproteins gHgL. J. Virol. 85:13214-13223.
19. Chesnokova L, Nishimura S, Hutt-Fletcher LM. 2009. Fusion of epithelial cells by Epstein-Barr virus proteins is triggered by binding of viral glycoproteins gHgL to integrins αvβ6 or αvβ8. Proc. Natl. Acad. Sci. U. S. A. 106:20464-20469.
20. Borza C, Morgan A, Turk S, Hutt-Fletcher LM. 2004. Use of gHgL for attachment of Epstein-Barr virus to epithelial cells compromises infection. J. Virol. 78:5007-5014.
21. Kirschner A, Lowrey A, Longnecker R, Jardetzky T. 2007. Binding-site interactions between Epstein-Barr virus fusion proteins gp42 and gH/gL reveal a peptide that inhibits both epithelial and B-cell membrane fusion. J. Virol. 81:9216-9229.
22. Borza C, Hutt-Fletcher LM. 2002. Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus. Nat. Med. 8:594- 599.
23. Wang X, Kenyon W, Li Q, Mullberg J, Hutt-Fletcher LM. 1998. Epstein- Barr virus uses different complexes of glycoproteins gH and gL to infect B lymphocytes and epithelial cells. J. Virol. 72:5552-5558.
24. Vanarsdall A, Ryckman B, Chase M, Johnson D. 2008. Human cytomegalovirus glycoproteins gB and gH/gL mediate epithelial cell-cell fusion when expressed either in cis or in trans. J. Virol. 82:11837-11850.
25. Adler B, Scrivano L, Ruzcics Z, Rupp B, Sinzger C, Koszinowski U. 2006. Role of human cytomegalovirus UL131A in cell type-specific virus entry and release. J. Gen. Virol. 87:2451-2460.
26. Huber M, Compton T. 1997. Characterization of a novel third member of the human cytomegalovirus glycoprotein H-glycoprotein L complex. J. Virol. 71:5391-5398.
27. Li L, Nelson J, Britt W. 1997. Glycoprotein H-related complexes of human cytomegalovirus: identification of a third protein in the gCIII complex. J. Virol. 71:3090-3097.
28. Wang D, Shenk T. 2005. Human cytomegalovirus UL131 open reading frame is required for epithelial cell tropism. J. Virol. 79:10330-10338.
29. Ryckman B, Chase M, Johnson D. 2010. Human cytomegalovirus TR strain glycoproteinOacts as a chaperone promoting gH/gL incorporation into virions but is not present in virions. J. Virol. 84:2597-2609.
30. Ryckman B, Rainish B, Chase M, Borton J, Nelson J, Jarvis M, Johnson D. 2008. Characterization of the human cytomegalovirus gH/gL/UL128- 131 complex that mediates entry into epithelial and endothelial cells. J. Virol. 82:60-70.
31. Ryckman B, Jarvis M, Drummond D, Nelson J, Johnson D. 2006. Human cytomegalovirus entry into epithelial and endothelial cells depends on genes UL128 to UL150 and occurs by endocytosis and low-pH fusion. J. Virol. 80:710-722.
32. Wang D, Shenk T. 2005. Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism. Proc. Natl. Acad. Sci. U. S. A. 102:18153-18158.
33. Hahn G, Revello M, Patrone M, Percivalle E, Campanini G, Sarasini A, Wagner M, Gallina A, Milanesi G, Koszinowski U, Baldanti F, Gerna G. 2004. Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes. J. Virol. 78:10023-10033.
34. Ryckman B, Chase M, Johnson D. 2008. HCMV gH/gL/UL128-131 interferes with virus entry into epithelial cells: evidence for cell typespecific receptors. Proc. Natl. Acad. Sci. U. S. A. 105:14118-14123.
35. Rasmussen L, Geissler A, Cowan C, Chase A, Winters M. 2002. The genes encoding the gCIII complex of human cytomegalovirus exist in highly diverse combinations in clinical isolates. J. Virol. 76:10841-10848.
36. Stanton R, Westmoreland D, Fox J, Davison A, Wilkinson G. 2005. Stability of human cytomegalovirus genotypes in persistently infected renal transplant recipients. J. Med. Virol. 75:42-46.
37. Gorzer I, Guelly C, Trajanoski S, Puchhammer-Stockl E. 2010. Deep sequencing reveals highly complex dynamics of human cytomegalovirus genotypes in transplant patients over time. J. Virol. 84:7195-7203.
38. Huber M, Compton T. 1998. The human cytomegalovirus UL74 gene encodes the third component of the glycoprotein H-glycoprotein L-containing envelope complex. J. Virol. 72:8191-8197.
39. Huber M, Compton T. 1999. Intracellular formation and processing of the heterotrimeric gH-gL-gO (gCIII) glycoprotein envelope complex of human cytomegalovirus. J. Virol. 73:3886-3892.
40. Dunn W, Chou C, Li H, Hai R, Patterson D, Stolc V, Zhu H, Liu F. 2003. Functional profiling of a human cytomegalovirus genome. Proc. Natl. Acad. Sci. U. S. A. 100:14223-14228.
41. Hobom U, Brune W, Messerle M, Hahn G, Koszinowski U. 2000. Fast screening procedures for random transposon libraries of cloned herpesvirus genomes: mutational analysis of human cytomegalovirus envelope glycoprotein genes. J. Virol. 74:7720-7729.
42. Jiang X, Adler B, Sampaio K, Digel M, Jahn G, Ettischer N, Stierhof Y, Scrivano L, Koszinowski U, Mach M, Sinzger C. 2008. UL74 of human cytomegalovirus contributes to virus release by promoting secondary envelopment of virions. J. Virol. 82:2802-2812.
43. Wille P, Knoche A, Nelson J, Jarvis M, Johnson D. 2010. A human cytomegalovirus gO-null mutant fails to incorporate gH/gL into the virion envelope and is unable to enter fibroblasts and epithelial and endothelial cells. J. Virol. 84:2585-2596.
44. Stanton R, Baluchova K, Dargan D, Cunningham C, Sheehy O, Seirafian S, McSharry B, Neale M, Davies J, Tomasec P, Davison A, Wilkinson G. 2010. Reconstruction of the complete human cytomegalovirus genome in a BAC reveals RL13 to be a potent inhibitor of replication. J. Clin. Invest. 120:3191-3208.
45. Murphy E, Yu D, Grimwood J, Schmutz J, Dickson M, Jarvis M, Hahn G, Nelson J, Myers R, Shenk T. 2003. Coding potential of laboratory and clinical strains of human cytomegalovirus. Proc. Natl. Acad. Sci. U. S. A. 100:14976-14981.
46. Sinzger C, Hahn G, Digel M, Katona R, Sampaio K, Messerle M, Hengel H, Koszinowski U, Brune W, Adler B. 2008. Cloning and sequencing of a highly productive, endotheliotropic virus strain derived from human cytomegalovirus TB40/E. J. Gen. Virol. 89:359-368.
47. Reed LJ, Muench H. 1938. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. 27:493-497.
48. Dolan A, Cunningham C, Hector R, Hassan-Walker AF, Lee L, Addison C, Dargan D, McGeoch D, Gatherer D, Emery V, Griffiths P, Sinzger C, McSharry B, Wilkinson G, Davison A. 2004. Genetic content of wildtype human cytomegalovirus. J. Gen. Virol. 85:1301-1312.
49. Bogner E, Reschke M, Reis B, Reis E, Britt W, Radsak K. 1992. Recognition of compartmentalized intracellular analogs of glycoproteinH of human cytomegalovirus. Arch. Virol. 126:67-80.
50. Matthews D, Cummings D, Evelegh C, Graham F, Prevec L. 1999. Development and use of a 293 cell line expressing lac repressor for the rescue of recombinant adenoviruses expressing high levels of rabies virus glycoprotein. J. Gen. Virol. 80:345-353.
51. Cha T, Tom E, Kemble G, Duke G, Mocarski E, Spaete R. 1996. Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J. Virol. 70:78-83.
52. Gompels U, Nicholas J, Lawrence G, Jones M, Thomson B, Martin M, Efstathiou S, Craxton M, Macaulay H. 1995. The DNA sequence of human herpesvirus-6: structure, coding content, and genome evolution. Virology 209:29-51.
53. Rivailler P, Kaur A, Johnson R, Wang F. 2006. Genomic sequence of rhesus cytomegalovirus 180.92: insights into the coding potential of rhesus cytomegalovirus. J. Virol. 80:4179-4182.
54. Smith L, McWhorter A, Masters L, Shellam G, Redwood A. 2008. Laboratory strains of murine cytomegalovirus are genetically similar to but phenotypically distinct from wild strains of virus. J. Virol. 82:6689- 6696.
55. Theiler R, Compton T. 2002. Distinct glycoprotein O complexes arise in a post-Golgi compartment of cytomegalovirus-infected cells. J. Virol. 76: 2890-2898.
56. Akter P, Cunningham C, McSharry B, Dolan A, Addison C, Dargan D, Hassan-Walker AF, Emery V, Griffiths P, Wilkinson G, Davison A. 2003. Two novel spliced genes in human cytomegalovirus. J. Gen. Virol. 84:1117-1122.
57. Dargan D, Douglas E, Cunningham C, Jamieson F, Stanton R, Baluchova K, McSharry B, Tomasec P, Emery V, Percivalle E, Sarasini A, Gerna G, Wilkinson G, Davison A. 2010. Sequential mutations associated with adaptation of human cytomegalovirus to growth in cell culture. J. Gen. Virol. 91:1535-1546.
58. Gerna G, Percivalle E, Lilleri D, Lozza L, Fornara C, Hahn G, Baldanti F, Revello M. 2005. Dendritic-cell infection by human cytomegalovirus is restricted to strains carrying functional UL131-128 genes and mediates efficient viral antigen presentation to CD8+ T cells. J. Gen. Virol. 86:275- 284.
59. Hahn G, Rose D, Wagner M, Rhiel S, McVoy M. 2003. Cloning of the genomes of human cytomegalovirus strains Toledo, TownevarRIT3, and Townelong as BACs and site-directed mutagenesis using a PCR-based technique. Virology 307:164-177.
60. Luo M, Schwartz P, Fortunato E. 2008. Neonatal neural progenitor cells and their neuronal and glial cell derivatives are fully permissive for human cytomegalovirus infection. J. Virol. 82:9994-10007.
61. Rasmussen L, Geissler A, Winters M. 2003. Inter- and intragenic variations complicate the molecular epidemiology of human cytomegalovirus. J. Infect. Dis. 187:809-819.
62. Wang D, Yu Q, Schroer J, Murphy E, Shenk T. 2007. Human cytomegalovirus uses two distinct pathways to enter retinal pigmented epithelial cells. Proc. Natl. Acad. Sci. U. S. A. 104:20037-20042.
63. Scrivano L, Sinzger C, Nitschko H, Koszinowski U, Adler B. 2011. HCMV spread and cell tropism are determined by distinct virus populations. PLoS Pathog. 7:e1001256. doi:10.1371/journal.ppat.1001256.
64. Li L, Coelingh K, Britt W. 1995. Human cytomegalovirus neutralizing antibody-resistant phenotype is associated with reduced expression of glycoprotein H. J. Virol. 69:6047-6053.
65. Vanarsdall A, Chase M, Johnson D. 2011. Human cytomegalovirus glycoprotein gO complexes with gH/gL, promoting interference with viral entry into human fibroblasts but not entry into epithelial cells. J. Virol. 85:11638-11645.
66. Jiang X, Sampaio K, Ettischer N, Stierhof Y, Jahn G, Kropff B, Mach M, Sinzger C. 2011. UL74 of human cytomegalovirus reduces the inhibitory effect of gH-specific and gB-specific antibodies. Arch. Virol. 156:2145- 2155.